Non-Hodgkin’s lymphoma trials increase in the 5 years since 2019

According to GlobalData’s Clinical Trials Database, since 2019 there has been a notable increase in the number of clinical trials focusing on advancing the understanding and treatment of non-Hodgkin’s lymphoma. Although there was a slight decline in the number of trials in 2022, the figure rebounded in 2023 to 471 trials, indicating sustained interest and commitment within the research community towards exploring novel treatment modalities for NHL.